Skip to main content
Caplight Logo









theblood

theblood

Private
BerlinHealthcare & Life Scienceshttps://theblood.io

Last Round

Seed

May 10, 2024

Total Funding Raised

$1.06M

Company Overview

theblood is a FemTech company that provides an at-home test kit for non-invasive menstrual blood analysis to help women monitor their health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, D2C Brands, Subscription Commerce, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS, Data as a Service, Hardware Sales

AI Layer

Non-AI

Keywords

menstrual blood analysisat-home health testfemtechwomen's healthnon-invasive diagnosticsperiod blood testhormone testinghealth test subscriptiondigital healthD2C healthbiomarker testingmenstrual healthmHealthgender data gapprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

theblood Comparables

Compare theblood with similar companies based on industry and business-model similarity.

theblood comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Diamens
81%
Hormona
80%
Qvin
80%

theblood Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 10, 2024
Pre SeedMar 14, 2023

theblood Investors

Notable investors and investment history

theblood investors
InvestorRounds
RoX HealthPre Seed

theblood Filings

Explore SEC and related filing metadata, where available.

theblood filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about theblood's valuation, stock price, and market status.

Is theblood a public or private company?

theblood is a private company.

What is the current stock price of theblood?

theblood is a private company with no public stock price. No recent secondary market data is available.

How much is theblood worth (valuation)?

Valuation information for theblood is not publicly available.

Can I buy theblood stock?

theblood shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was theblood's last funding round?

theblood's most recent funding round was Seed on May 10, 2024.

Who are the main investors in theblood?

Key investors in theblood include RoX Health.

Will theblood IPO soon?

No public IPO plans have been announced for theblood.

How can I track theblood secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor theblood's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range13
Year Founded2022
Last FundingMay 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?